We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
What Are the Data Behind ATT?
Richard S. Isaacson, MD
Pierre N. Tariot, MD
Gayatri Devi, MD, MS, FAAN, FACP
How Should We Monitor Patients on Amyloid-Targeting Therapy?
Is Amyloid-Targeting Therapy Worth It?
How Do You Counsel Patients About Amyloid-Related Imaging Abnormalities?
The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy
Do Women Respond Differently to ATT Than Men?
Which Biomarkers Do You Recommend to Confirm Amyloid Positivity?
How Much Should We Worry About Amyloid-Related Imaging Abnormalities?
Pediatric Narcolepsy: Addressing the Challenges in Its Recognition, Diagnosis, and Management
Michael J. Thorpy, MD
Anne Marie Morse, DO
Sodium Oxybate in the Management of Narcolepsy: One Molecule, Three Formulations – and the Critical Role of Shared Decision-Making in Its Use
Clete A. Kushida, MD, PhD
Managing TRAEs and Minimizing Hyperglycemia
Kevin C.J. Yuen, MD
Susan L Samson, MD, PhD, FRCPC, FACE
Best Practices for Individualizing Treatment Selection
Eliza B. Geer, MD
Making a Definitive Diagnosis
Could Your Patient’s Symptoms Be Acromegaly?
Refining Screening and Referral in Frontline Care Settings
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education